Lakewood-Amedex Biotherapeutics, Inc. (LABT)
0.2373
-0.05
(-16.74%)
USD |
NASDAQ |
Oct 29, 16:00
0.2082
-0.03
(-12.26%)
After-Hours: 05:03
Lakewood-Amedex Biotherapeutics Total Assets (Quarterly) : 4.96M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.96M |
| March 31, 2026 | 0.1963M |
| December 31, 2025 | 0.4816M |
| September 30, 2025 | 0.9851M |
| Date | Value |
|---|---|
| June 30, 2025 | 1.558M |
| March 31, 2025 | 0.8179M |
| December 31, 2024 | 1.071M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.6289M |
| Shareholders Equity (Quarterly) | 4.331M |
| Debt to Equity Ratio | 0.0235 |
| Current Ratio | 7.704 |
| Net Debt Paydown Yield | 1.01% |